Sasser AK - Search Results

1

Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, Marini F. Hall B, et al. Among authors: sasser ak. Int J Hematol. 2007 Jul;86(1):8-16. doi: 10.1532/IJH97.06230. Int J Hematol. 2007. PMID: 17675260 Review.

2

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.

Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F. Spaeth EL, et al. Among authors: sasser ak. PLoS One. 2009;4(4):e4992. doi: 10.1371/journal.pone.0004992. Epub 2009 Apr 7. PLoS One. 2009. PMID: 19352430 Free PMC article.

3

Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments.

Sasser AK, Mundy BL, Smith KM, Studebaker AW, Axel AE, Haidet AM, Fernandez SA, Hall BM. Sasser AK, et al. Cancer Lett. 2007 Sep 8;254(2):255-64. doi: 10.1016/j.canlet.2007.03.012. Epub 2007 Apr 27. Cancer Lett. 2007. PMID: 17467167

4

Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan MW, Marini FC, Rosol TJ, Bonafé M, Hall BM. Studebaker AW, et al. Among authors: sasser ak. Cancer Res. 2008 Nov 1;68(21):9087-95. doi: 10.1158/0008-5472.CAN-08-0400. Cancer Res. 2008. PMID: 18974155

5

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM. Sullivan NJ, et al. Among authors: sasser ak. Oncogene. 2009 Aug 20;28(33):2940-7. doi: 10.1038/onc.2009.180. Epub 2009 Jul 6. Oncogene. 2009. PMID: 19581928 Free PMC article.

6

Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer.

Sasser AK, Sullivan NJ, Studebaker AW, Hendey LF, Axel AE, Hall BM. Sasser AK, et al. FASEB J. 2007 Nov;21(13):3763-70. doi: 10.1096/fj.07-8832com. Epub 2007 Jun 22. FASEB J. 2007. PMID: 17586727

7

STAT3 can be activated through paracrine signaling in breast epithelial cells.

Lieblein JC, Ball S, Hutzen B, Sasser AK, Lin HJ, Huang TH, Hall BM, Lin J. Lieblein JC, et al. Among authors: sasser ak. BMC Cancer. 2008 Oct 21;8:302. doi: 10.1186/1471-2407-8-302. BMC Cancer. 2008. PMID: 18939993 Free PMC article.

8

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.

Casneuf T, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK. Casneuf T, et al. Among authors: sasser ak. Breast Cancer (Dove Med Press). 2016 Feb 3;8:13-27. doi: 10.2147/BCTT.S92414. eCollection 2016. Breast Cancer (Dove Med Press). 2016. PMID: 26893580 Free PMC article.

9

Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes.

Arnold GS, Sasser AK, Stachler MD, Bartlett JS. Arnold GS, et al. Among authors: sasser ak. Mol Ther. 2006 Jul;14(1):97-106. doi: 10.1016/j.ymthe.2006.02.014. Epub 2006 Apr 19. Mol Ther. 2006. PMID: 16624620 Free article.

10

Modified adeno-associated virus (AAV) vectors: A new generation of targeted gene therapy delivery systems.

Sasser AK, Bartlett JS. Sasser AK, et al. Discov Med. 2003 Dec;3(19):28-30. Discov Med. 2003. PMID: 20705032 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters